Texas Bank & Trust’s Amgen AMGN Stock Holding History

Texas Bank & Trust’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$563K	Sell	1,599 -9	-0.6%	-$3.21K	0.21%	109
2025 Q4	$526K	Hold	1,608	–	–	0.19%	112
2025 Q3	$454K	Buy	1,608 +26	+2%	+$7.54K	0.17%	116
2025 Q2	$442K	Hold	1,582	–	–	0.18%	118
2025 Q1	$493K	Buy	1,582 +733	+86%	+$216K	0.21%	111
2024 Q4	$221K	Buy	+849	New	+$252K	0.09%	171

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Texas Bank & Trust's AMGN Position: Q1 2026 in Review

Texas Bank & Trust reduced its Amgen (AMGN) stake by 0.56% in Q1 2026, selling an estimated $3.21K and leaving 1,599 shares worth $563K. The position accounts for 0.21% of the portfolio, ranked #109.

Texas Bank & Trust first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Texas Bank & Trust held 1,599 shares of Amgen worth $563K as of Q1 2026.
Texas Bank & Trust sold 9 Amgen shares in Q1 2026, an estimated $3.21K.
Amgen made up 0.21% of Texas Bank & Trust's portfolio in Q1 2026, its #109 holding.
Texas Bank & Trust first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Texas Bank & Trust's 13F filing for Q1 2026, filed 30 Apr 2026.